When it comes to opiates, just say NO

Journal of Clinical Investigation

Volumn 117, Issue 11, 2007, Pages 3185-3187

  Pasternak, Gavril W ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

3 NITROTYROSINE; ADENYLATE CYCLASE; CHOLECYSTOKININ; DELTA OPIATE RECEPTOR; ENKEPHALIN; GLUTAMATE AMMONIA LIGASE; GLUTAMATE RECEPTOR; GLYCOPROTEIN P; GUANINE NUCLEOTIDE BINDING PROTEIN; GUANYLATE CYCLASE; MORPHINE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; NEUROPEPTIDE FF; NEUROTRANSMITTER; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; NITRIC OXIDE; NOCICEPTIN; OPIATE DERIVATIVE; OPIATE RECEPTOR; PEROXYNITRITE; PROTEIN DERIVATIVE; RGS PROTEIN; SUPEROXIDE DISMUTASE; TYROSINE; VESICULAR GLUTAMATE TRANSPORTER 1;

ANALGESIA; CHRONIC PAIN; CONFUSION; CONSTIPATION; DRUG EFFECT; DRUG MECHANISM; DRUG TOLERANCE; HUMAN; NONHUMAN; OPIATE ADDICTION; PRIORITY JOURNAL; RESPIRATION DEPRESSION; REVIEW; SEDATION; SIDE EFFECT;

ANALGESICS, OPIOID; ANIMALS; DRUG TOLERANCE; MICE; MORPHINE; NITRIC OXIDE; PEROXYNITROUS ACID; RECEPTORS, N-METHYL-D-ASPARTATE; SIGNAL TRANSDUCTION; TYROSINE;

EID: 36048993026     PISSN: 00219738     EISSN: 15588238     Source Type: Journal    
DOI: 10.1172/JCI34035     Document Type: Review

References (22)

1. Inturrisi, C.E. 1994. NMDA receptors, nitric oxide and opioid tolerance. Regul. Pept. 54:129-130.
2. Pasternak, G.W., and Inturrisi, C. 1995. Pharmacological modulation of opioid tolerance. Exp. Opin. Invest. Drugs. 4:271-281.
3. Foley, K.M. 1996. Pain syndromes in patients with cancer. In Pain management: theory and practice. R.K. Portenoy and R.M. Kanner, editors. F.A. Davis Company. Philadelphia, Pennsylvania, USA. 191-215.
4. Foley, K.M. 1996. Controlling the pain of cancer. Sci. Am. 275:164-165.
5. Payne, R., and Pasternak, G.W. 1992. Pharmacology of pain treatment. In Contemporary neurology series: scientific basis of neurologic drug therapy. M.V. Johnston, R. MacDonald, and A.B. Young, editors. Davis. Philadelphia, Pennsylvania, USA. 268-301.
6. Portenoy, R.K. 2000. Current pharmacotherapy of chronic pain. J. Pain Symptom Manage. 19:S16-S20.
7. Collier, H.O. 1980. Cellular site of opiate dependence. Nature. 283:625-629.
8. Roerig, S.C., O'Brien, S.M., Fujimoto, J.A., and Wilcox, G.L. 1984. Tolerance to morphine analgesia: decreased multiplicative interaction between spinal and supraspinal sites. Brain Res. 308:360-363.
9. Aquilante, C.L., Letrent, S.P., Pollack, G.M., and Brouwer, K.L.R. 1999. Increased brain P-glycoprotein in morphine tolerant rats. Life Sci. 66:PL47-PL51.
10. King, M., Su, W., Chang, A., Zuckerman, A., and Pasternak, G.W. 2001. Transport of opioids from the brain to the periphery by P-glycoprotein: peripheral actions of central drugs. Nat. Neurosci. 4:268-274.
11. Trujillo, K.A., and Akil, H. 1991. Inhibition of morphine tolerance and dependence by the NMDA receptor anagonist MK-801. Science. 251:85-87.
12. Ben-Eliyahu, S., et al. 1992. The NMDA receptor antagonist MK-801 prevents long-lasting nonassociative morphine tolerance in the rat. Brain Res. 575:304-308.
13. Kolesnikov, Y.A., Pick, C.G., and Pasternak, G.W. 1992. NG-Nitro-L-arginine prevents morphine tolerance. Eur. J. Pharmacol. 221:399-400.
14. Kolesnikov, Y.A., Pick, C.G., Ciszewska, G., and Pasternak, G.W. 1993. Blockade of tolerance to morphine but not to kappa opioids by a nitric oxide synthase inhibitor. Proc. Natl. Acad. Sci. U. S. A. 90:5162-5166.
15. Inturrisi, C.E. 2002. Clinical pharmacology of opioids for pain. Clin. J. Pain. 18:S3-S13.
16. Pasternak, G.W., and Kolesnikov, Y. 2005. The NMDA/Nitric oxide synthase cascade in opioid analgesia and tolerance. In Contemporary clinical neuroscience: glutamate and addiction. B.H. Herman, et al., editors. Humana Press. Totowa, New Jersey, USA. 409-416.
17. Kolesnikov, Y., Jain, S., Wilson, R., and Pasternak, G.W. 1998. Lack of morphine and enkephalin tolerance in 129/SvEv mice: Evidence for a NMDA receptor defect. J. Pharmacol. Exp. Ther. 284:455-459.
18. Bredt, D.S., and Snyder, S.H. 1994. Nitric oxide: A physiologic messenger molecule. Ann. Rev. Biochem. 63:175-195.
19. Jaffrey, S.R., Erdjument-Bromage, H., Ferris, C.D., Tempst, P., and Snyder, S.H. 2001. Protein S-nitrosylation: a physiological signal for neuronal nitric oxide. Nat. Cell Biol. 3:193-197.
20. Muscoli, C., et al. 2007. Therapeutic manipulation of peroxynitrite attenuates the development of opiate-induced antinociceptive tolerance in mice. J. Clin. Invest. 117:3530-3539.
21. Kolesnikov, Y.A., et al. 1997. Functionally differentiating two neuronal nitric oxide synthase isoforms through antisense mapping: Evidence for opposing NO actions on morphine analgesia and tolerance. Proc. Natl. Acad. Sci. U. S. A. 94:8220-8225.
22. Babey, A.M., et al. 1994. Nitric oxide and opioid tolerance. Neuropharmacology. 33:1463-1470.